/ Unknown statusPhase 2/3 Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Renal Denervation in Patients With Resistant Hypertension
The TIVUS II is a prospective, multicenter, non-randomized, open-label clinical study of the safety and performance of the TIVUS™ System consisting of three (3) concurrent cohorts:
TIVUS™ Severe Resistant HTN Cohort
TIVUS™ Moderate Resistant HTN Cohort
TIVUS™ Failed RF Therapy Cohort
100 Clinical Results associated with Cardiosonic, Inc.
0 Patents (Medical) associated with Cardiosonic, Inc.
100 Deals associated with Cardiosonic, Inc.
100 Translational Medicine associated with Cardiosonic, Inc.